Observation of Efficacy of Lianhua Qingwen Capsule on Lung Infection

, by wangshuhong, 1 min reading time

The first paragraph was from 10 year ago one research, and the second one was from  Academician Zhong Nanshan and his research team.

 

infection.Methods:Sixty patients with lung infection were randomly grouped to control group receiving ceftriaxone sodium or Lavofloxacin Lactate, and treatment group receiving Lianhua Qingwen Capsule in additional to controlled medication for 7 days. To observe bacteria clearance rate, clinical manifestation, physical signs, total effective rate, and untoward actions respectively.Results:The bacteria clearance rate of the treatment group was 80.0% compared to 50.0% of the control group, the total effective rate of the treatment group was 96.7% compared to 83.3% of the control group (P<0.05). Untoward action incidence rate of the treatment group was 33.3% compared to 26.7% of the control group (P>0.05).Conclusion:Lianhua Qingwen Capsule is safe and has significant efficacy for lung infection.

 

The below content can be translate to your language by google translate if you are interesting in that.

 

钟南山团队:连花清瘟有抑制新冠病毒细胞复制的作用
新京报 2020-03-23 23:11:03
新京报讯(记者 张秀兰)新京报记者23日获悉,国外期刊《药理学研究》(Pharmacological Research,IF 5.572)近日在线刊出名为《连花清瘟对新型冠状病毒具有抗病毒、抗炎作用》的研究文章,论文作者包括广州医科大学呼吸疾病国家重点实验室主任钟南山、研究员杨子峰等。文章显示,连花清瘟能显著抑制新型冠状病毒(SARS-CoV-2)在细胞中的复制,从而发挥抗新冠病毒活性的作用。
研究结果显示,连花清瘟能够显著抑制SARS-CoV-2在Vero E6细胞中的复制,并明显降低促炎细胞因子(TNF-α,IL-6,CCL-2/MCP-1和CXCL-10/IP-10)的表达水平。总体来说,体外实验显示连花清瘟能显著抑制新冠病毒的复制,影响病毒形态,发挥抗炎作用。
此前,钟南山院士团队曾在广东疫情防控发布会上表示,研究证实连花清瘟在体外有显著抑制新型冠状病毒的细胞病变效应;对新冠病毒感染细胞和诱导的TNF-α、IL-6等炎性因子过度表达有抑制作用。
新冠疫情暴发以来,连花清瘟胶囊(颗粒)先后被国家及20余个省市新冠肺炎诊疗方案推荐,在火神山、雷神山及方舱医院等医疗机构广泛使用。新京报记者查询国家药监局官网获悉,连花清瘟胶囊国内目前仅有以岭药业获批,为以岭药业主力产品,国家医保甲类品种,已先后17次被列入国家卫健委、中医药管理局发布的甲型流感、乙型流感、禽流感等呼吸道疾病相关诊疗方案的用药推荐。2015年12月,连花清瘟胶囊获准进入美国食药监局(FDA)二期临床研究,成为全球首个进入FDA临床研究的治感冒抗流感复方中药。
米内网数据显示,在2017年度中成药感冒用药销售收入排名中,连花清瘟颗粒和连花清瘟胶囊分别排名第二、第四,市场份额分别为6.24%、4.21%。日前,河北省药监局正式批复同意石家庄以岭药业有限公司委托北京以岭药业有限公司生产连花清瘟胶囊,这使连花清瘟胶囊日产量再增加300万粒,达到日产5300万粒。
编辑 岳清秀 校对 贾宁


Blog posts

Login

Forgot your password?

Don't have an account yet?
Create account